Dr. Lerwill is co-director of the Breast Pathology Service at Massachusetts General Hospital. She lectures in graduate medical education courses in the United States and abroad.
- Centers & Specialties
- Clinical Interests
- Breast pathology
- Gynecologic pathology
- Medical Education
- MD, Harvard Medical School
- Residency, Massachusetts General Hospital
- Board Certifications
- Anatomic Pathology
- Boston: Massachusetts General Hospital
- Insurances Accepted
- Aetna Health Inc.
- Beech Street
- Blue Cross Blue Shield - Blue Care 65
- Blue Cross Blue Shield - Indemnity
- Blue Cross Blue Shield - Managed Care
- Blue Cross Blue Shield - Partners Plus
- Cigna (PAL #'s)
- Fallon Community HealthCare
- Great-West Healthcare (formally One Health Plan)
- Harvard Pilgrim Health Plan - PBO
- Health Care Value Management (HCVM)
- Humana/Choice Care PPO
- Medicare - ACD
- Neighborhood Health Plan - ACD
- Neighborhood Health Plan - PBO
- OSW - Maine
- OSW - New Hampshire
- OSW - Rhode Island
- Private Health Care Systems (PHCS)
- Railroad Medicare
- Railroad Medicare - ACD
- Senior Whole Health
- Tufts Health Plan
- United Healthcare (non-HMO) - ACD
- United Healthcare (non-HMO) - PBO
Note: This provider may accept more insurance plans than shown; please call the practice to find out if your plan is accepted.
- Patient Age Group
Dr. Lerwill received her medical degree from Harvard Medical School. She completed her residency in anatomic pathology and a fellowship in breast and gynecologic pathology at Massachusetts General Hospital. Her main research interests include early neoplasia of the breast, biphasic tumors of the breast, use of immunohistochemistry in diagnostic breast pathology, and metastatic lesions to the gynecological tract. Her academic work focuses on practical aspects of diagnostic breast and gynecologic pathology, and she is a frequent speaker at pathology postgraduate courses.
- Research Summary
Current areas of clinicopathologic investigation include:
Early epithelial neoplasia of the breast
Phyllodes tumors and other biphasic lesions of the breast
Use of immunohistochemistry as a diagnostic aid in breast pathology
Metastatic tumors to the ovary
- Case records of the Massachusetts General Hospital. Case 1-2015. A 66-year-old woman with metastatic breast cancer after endocrine therapy. Moy B, Specht MC, Lanuti M, Rafferty EA, Lerwill MF. N Engl J Med. 2015 Jan 8;372(2):162-70. doi: 10.1056/NEJMcpc1408601. No abstract available.
- Computational pathology to discriminate benign from malignant intraductal proliferations of the breast. Dong F, Irshad H, Oh EY, Lerwill MF, Brachtel EF, Jones NC, Knoblauch NW, Montaser-Kouhsari L, Johnson NB, Rao LK, Faulkner-Jones B, Wilbur DC, Schnitt SJ, Beck AH. PLoS One. 2014 Dec 9;9(12):e114885. doi: 10.1371/journal.pone.0114885. eCollection 2014.
- Case records of the Massachusetts General Hospital. Case 17-2011. A 49-year-old woman with a mass in the breast and overlying skin changes. Overmoyer BA, Lee JM, Lerwill MF. N Engl J Med. 2011 Jun 9;364(23):2246-54. doi: 10.1056/NEJMcpc1100922. No abstract available.
55 Fruit Street
Boston MA, 02114-2696